You must log in to view this webinar.

Combating A Silent Killer: An Evidence-Based Update on the Treatment of Hypertension

1.0 CME

After watching the webcast you will be automatically forwarded to the evaluation to earn your CME credits.

SPEAKER NAME /
CREDENTIALS

Joseph Saseen, PharmD, CLS

Professor and Vice Chair, Clinical Pharmacy

Professor Family Medicine

University of Colorado Anschutz Medical Campus

Time of Talk

45 minutes

CME Accreditation

45 min webcast = 0.75 credits

15 min exam = 0.25 credits

Total = 1.0 credits

Description:

Hypertension mortality has been on the rise for the past decade. This talk will review recent evidence evaluating the specific use of antihypertensive medications to empower clinicians to maximize their care of patients with hypertension.

Learning Objectives

  1. Explain recommendations from the 2017 American College of Cardiology/American Heart Association guideline for treatment of patients with hypertension
  2. Describe the evidence supporting bedtime dosing of antihypertensive medications
  3. Formulate a care plan for patients with resistant hypertension based on the 2018 American Heart Association scientific statement

Disclosures:

None

The AAFP has reviewed Cleveland HeartLab CME Webcasts, and deemed it acceptable for AAFP credit. Term of approval is from 04/05/2021 to 04/04/2022. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Credit approval includes the following session(s): 1.00 Enduring Materials, Self-Study AAFP Prescribed Credit(s) - Combating A Silent Killer: An Evidence-Based Update on the Treatment of Hypertension